Surgical Science Sweden ABSUSRF -2.20%82 PS Ratio is 1.96 as of Jun. 30, 2026, which is 80% below its 10-year median of 9.98. GuruFocus rates SUSRF with a GF Score™ of 82/100 and a GF Value™ of $19.33 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 657 Healthcare Providers & Services companies, Surgical Science Sweden AB ranks worse than 52.97% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Surgical Science Sweden AB's share price is $4.00.
Surgical Science Sweden AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $2.04. Hence, Surgical Science Sweden AB's PS Ratio for today is 1.96.
The historical rank and industry rank for Surgical Science Sweden AB's PS Ratio or its related term are showing as below:
SUSRF'
s PS Ratio Range Over the Past 10 Years
Min: 1.27 Med: 9.98 Max: 72.19
Current: 1.65
During the past 11 years, Surgical Science Sweden AB's highest PS Ratio was 72.19. The lowest was 1.27. And the median was 9.98.
SUSRF's PS Ratio is ranked worse than 52.97% of 657
companies
in the Healthcare Providers & Services industry
Industry Median: 1.51
vs SUSRF: 1.65
Surgical Science Sweden AB revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Surgical Science Sweden AB was 3.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 7.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 38.80% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 28.60% per year.
During the past 11 years, Surgical Science Sweden AB's highest 3-Year average Revenue per Share Growth Rate was 78.50% per year. The lowest was -1.20% per year. And the median was 19.15% per year.
Back to Basics: PS Ratio
Surgical Science Sweden AB (OTCPK:SUSRF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Surgical Science Sweden AB PS Ratio Related Terms
Surgical Science Sweden AB PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Surgical Science Sweden AB's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgical Science Sweden AB PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Surgical Science Sweden AB's PS Ratio distribution charts can be found below:
* The bar in red indicates where Surgical Science Sweden AB's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Surgical Science Sweden AB's Share Price of today is $4.00. Surgical Science Sweden AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.04.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Surgical Science Sweden AB (SUSRF) has a PS Ratio of 1.96 as of Jun. 30, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Surgical Science Sweden AB and its competitors. This is 80% below median its historical median of 9.98. Over the past decade, Surgical Science Sweden AB's PS Ratio has ranged from 1.27 to 72.19. According to the industry distribution chart, Surgical Science Sweden AB ranks #348 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 53%.
Is Surgical Science Sweden AB's PS Ratio too high?
Surgical Science Sweden AB's current PS Ratio of 1.96 is 80% below median its 10-year median of 9.98. Over the past 10 years, this metric has ranged from a low of 1.27 to a high of 72.19. The Healthcare Providers & Services industry median PS Ratio is 1.51. Surgical Science Sweden AB's value of 1.96 is 29.8% above this industry median. Based on the distribution chart, Surgical Science Sweden AB ranks #348 out of 657 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Surgical Science Sweden AB has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Surgical Science Sweden AB's PS Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Surgical Science Sweden AB ranks #348 out of 657 companies for PS Ratio. This places Surgical Science Sweden AB in the lower half of its industry. The industry median PS Ratio is 1.51. Surgical Science Sweden AB's value of 1.96 is 29.8% above this benchmark. Historically, Surgical Science Sweden AB's own PS Ratio has ranged from 1.27 to 72.19 over the past decade. While the company's 10-year median is 9.98 vs. the industry median of 1.51, Surgical Science Sweden AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.51, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgical Science Sweden AB's current PS Ratio of 1.96 is 29.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Surgical Science Sweden AB and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgical Science Sweden AB's current PS Ratio is 1.96, which is 80% below median its own 10-year median of 9.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Science Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Surgical Science Sweden AB (SUSRF) is currently considered Significantly Undervalued. The stock's GF Value™ is $19.33, compared to a current price of $4.00 — trading 79.3% below its estimated fair value. The current PS Ratio is 1.96, which is 80% below median its 10-year median of 9.98 and 29.8% above the Healthcare Providers & Services industry median of 1.51. Surgical Science Sweden AB's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Surgical Science Sweden AB (SUSRF), the current PS Ratio is 1.96 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surgical Science Sweden AB (SUSRF) Overvalued in 2026?
Based on GuruFocus' analysis, Surgical Science Sweden AB stock appears to be undervalued.
The current stock price of $4.00 is trading 79.3% below its estimated GF Value™ of $19.33.
GuruFocus considers Surgical Science Sweden AB to be Significantly Undervalued.
Key valuation signals for SUSRF:
PS Ratio: 1.96 (80% below median its 10-year median of 9.98)
GF Value™: $19.33 vs. price of $4.00 (79.3% below fair value)
Industry Position: 29.8% above the Healthcare Providers & Services median (#348 of 657)
No single metric tells the full story. See the SUSRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments: Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations prior to entering the clinical environment, as well as support and services. Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments, and also simulators for medical device companies.
82GF Score
Get the complete analysis for SUSRF
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SUSRF has been successfully added to your 
